Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $103.0400 (-0.08%) ($102.0000 - $105.1300) on Fri. May. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.28% (three month average) | RSI | 57 | Latest Price | $103.0400(-0.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 2% a day on average for past five trading days. | Weekly Trend | LGND advances 2.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(53%) XBI(50%) IWC(48%) IWM(48%) | Factors Impacting LGND price | LGND will decline at least -3.14% in a week (0% probabilities). VIXM(-25%) VXX(-16%) UUP(-16%) UNG(-2%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.14% (StdDev 6.28%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
5 Day Moving Average | $100.66(2.36%) | 10 Day Moving Average | $98.71(4.39%) | 20 Day Moving Average | $96.16(7.15%) | To recent high | -4.5% | To recent low | 62.6% | Market Cap | $1.656b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |